Terms: = Liver cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED AND Treatment
54 results:
1. Integrative analysis of disulfidptosis and immune microenvironment in hepatocellular carcinoma: a putative model and immunotherapeutic strategies.
Yang T; Liu J; Liu F; Lei J; Chen S; Ma Z; Ke P; Yang Q; Wen J; He Y; Duan J; Zeng X
Front Immunol; 2023; 14():1294677. PubMed ID: 38235128
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic and predictive biomarkers in paediatric solid tumours.
Glembocki AI; Somers GR
Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
[TBL] [Abstract] [Full Text] [Related]
3. Seven oxidative stress-related genes predict the prognosis of hepatocellular carcinoma.
Miao C; He X; Chen G; Kahlert UD; Yao C; Shi W; Su D; Hu L; Zhang Z
Aging (Albany NY); 2023 Dec; 15(24):15050-15063. PubMed ID: 38097352
[TBL] [Abstract] [Full Text] [Related]
4. LINC02561 promotes metastasis in HCC via HIF1-α/NDRG1/UPF1 axis.
Li SN; Li MX; Guo WW; Zhang LR; Ding YH; Wu XJ
Gene; 2024 Feb; 896():148033. PubMed ID: 38013127
[TBL] [Abstract] [Full Text] [Related]
5. Adaptation of the Th-mycn Mouse Model of Neuroblastoma for Evaluation of Disseminated Disease.
Rahavi SM; Aletaha M; Farrokhi A; Lorentzian A; Lange PF; Maxwell CA; Lim CJ; Reid GSD
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569447
[TBL] [Abstract] [Full Text] [Related]
6. A TGF-β-dominant chemoresistant phenotype of hepatoblastoma associated with aflatoxin exposure in children.
Xiang X; Hao Y; Cheng C; Hu H; Chen H; Tan J; Wang Y; Liu X; Peng B; Liao J; Wang J; Xie Y; Liu J; Chen S; Xu L; Xie W; Xue R; Kuang M; Xu Z; Jiang H; Peng S
Hepatology; 2024 Mar; 79(3):650-665. PubMed ID: 37459556
[TBL] [Abstract] [Full Text] [Related]
7. Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase.
Huang DQ; Tran A; Yeh ML; Yasuda S; Tsai PC; Huang CF; Dai CY; Ogawa E; Ishigami M; Ito T; Kozuka R; Enomoto M; Suzuki T; Yoshimaru Y; Preda CM; Marin RI; Sandra I; Tran S; Quek SXZ; Khine HHTW; Itokawa N; Atsukawa M; Uojima H; Watanabe T; Takahashi H; Inoue K; Maeda M; Hoang JK; Trinh L; Barnett S; Cheung R; Lim SG; Trinh HN; Chuang WL; Tanaka Y; Toyoda H; Yu ML; Nguyen MH
Hepatology; 2023 Nov; 78(5):1558-1568. PubMed ID: 37184202
[TBL] [Abstract] [Full Text] [Related]
8. Claudin-2 promotes colorectal cancer growth and metastasis by suppressing NDRG1 transcription.
Wei M; Zhang Y; Yang X; Ma P; Li Y; Wu Y; Chen X; Deng X; Yang T; Mao X; Qiu L; Meng W; Zhang B; Wang Z; Han J
Clin Transl Med; 2021 Dec; 11(12):e667. PubMed ID: 34965023
[TBL] [Abstract] [Full Text] [Related]
9. Molecular Mechanisms of Hepatoblastoma.
Zhang Y; Solinas A; Cairo S; Evert M; Chen X; Calvisi DF
Semin Liver Dis; 2021 Jan; 41(1):28-41. PubMed ID: 33764483
[TBL] [Abstract] [Full Text] [Related]
10. PGC7 promotes tumor oncogenic dedifferentiation through remodeling DNA methylation pattern for key developmental transcription factors.
Yan Q; Zhang Y; Fang X; Liu B; Wong TL; Gong L; Liu S; Yu D; Liu M; Jiang L; Wang X; Wei T; Jia Y; Li L; Sun L; Tang Y; Zhou N; Yuan YF; Li Y; Ma S; Guan XY
Cell Death Differ; 2021 Jun; 28(6):1955-1970. PubMed ID: 33500560
[TBL] [Abstract] [Full Text] [Related]
11. Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience.
Berlanga P; Pasqualini C; Pötschger U; Sangüesa C; Castellani MR; Cañete A; Luksch R; Elliot M; Schreier G; Kropf M; Morgenstern D; Papadakis V; Ash S; Ruud E; Brock P; Wieczorek A; Kogner P; Trahair T; Ambros P; Boterberg T; Castel V; Valteau-Couanet D; Ladenstein R
Eur J Cancer; 2021 Feb; 144():1-8. PubMed ID: 33316634
[TBL] [Abstract] [Full Text] [Related]
12. Diosgenin as a Novel Alternative Therapy for Inhibition of Growth, Invasion, and Angiogenesis Abilities of Different Glioblastoma Cell Lines.
Khathayer F; Ray SK
Neurochem Res; 2020 Oct; 45(10):2336-2351. PubMed ID: 32683533
[TBL] [Abstract] [Full Text] [Related]
13. Lipid desaturation-associated endoplasmic reticulum stress regulates mycn gene expression in hepatocellular carcinoma cells.
Qin XY; Su T; Yu W; Kojima S
Cell Death Dis; 2020 Jan; 11(1):66. PubMed ID: 31988297
[TBL] [Abstract] [Full Text] [Related]
14. Liposomal delivery of hydrophobic RAMBAs provides good bioavailability and significant enhancement of retinoic acid signalling in neuroblastoma tumour cells.
Bilip M; Shah S; Mathiyalakan M; Tagalakis AD; Hart SL; Maeshima R; Eaton S; Orford M; Irving E; Di Florio A; Simons C; Stoker AW
J Drug Target; 2020 Jul; 28(6):643-654. PubMed ID: 31903789
[TBL] [Abstract] [Full Text] [Related]
15. Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease.
Tas ML; Nagtegaal M; Kraal KCJM; Tytgat GAM; Abeling NGGM; Koster J; Pluijm SMF; Zwaan CM; de Keizer B; Molenaar JJ; van Noesel MM
Pediatr Blood Cancer; 2020 Apr; 67(4):e28061. PubMed ID: 31736229
[TBL] [Abstract] [Full Text] [Related]
16. Combined Aberrant Expression of NDRG2 and LDHA Predicts Hepatocellular Carcinoma Prognosis and Mediates the Anti-tumor Effect of Gemcitabine.
Guo Y; Li X; Sun X; Wang J; Yang X; Zhou X; Liu X; Liu W; Yuan J; Yao L; Li X; Shen L
Int J Biol Sci; 2019; 15(9):1771-1786. PubMed ID: 31523182
[TBL] [Abstract] [Full Text] [Related]
17. Targeting excessive mycn expression using MLN8237 and JQ1 impairs the growth of hepatoblastoma cells.
Eberherr C; Beck A; Vokuhl C; Becker K; Häberle B; Von Schweinitz D; Kappler R
Int J Oncol; 2019 May; 54(5):1853-1863. PubMed ID: 30864675
[TBL] [Abstract] [Full Text] [Related]
18. Widely metastatic IDH1-mutant glioblastoma with oligodendroglial features and atypical molecular findings: a case report and review of current challenges in molecular diagnostics.
Romo CG; Palsgrove DN; Sivakumar A; Elledge CR; Kleinberg LR; Chaichana KL; Gocke CD; Rodriguez FJ; Holdhoff M
Diagn Pathol; 2019 Feb; 14(1):16. PubMed ID: 30738431
[TBL] [Abstract] [Full Text] [Related]
19. A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate cancer: Efficacy and Biomarkers.
Beltran H; Oromendia C; Danila DC; Montgomery B; Hoimes C; Szmulewitz RZ; Vaishampayan U; Armstrong AJ; Stein M; Pinski J; Mosquera JM; Sailer V; Bareja R; Romanel A; Gumpeni N; Sboner A; Dardenne E; Puca L; Prandi D; Rubin MA; Scher HI; Rickman DS; Demichelis F; Nanus DM; Ballman KV; Tagawa ST
Clin Cancer Res; 2019 Jan; 25(1):43-51. PubMed ID: 30232224
[TBL] [Abstract] [Full Text] [Related]
20. Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study.
Morgenstern DA; Pötschger U; Moreno L; Papadakis V; Owens C; Ash S; Pasqualini C; Luksch R; Garaventa A; Canete A; Elliot M; Wieczorek A; Laureys G; Kogner P; Malis J; Ruud E; Beck-Popovic M; Schleiermacher G; Valteau-Couanet D; Ladenstein R
Pediatr Blood Cancer; 2018 Nov; 65(11):e27363. PubMed ID: 30015396
[TBL] [Abstract] [Full Text] [Related]
[Next]
